top of page
Top Nav.jpg

Solutions

Solutions-bg-image.jpg

Not sure where to start?

Now you can uncover the right solution for your business within a few clicks.

We measure demand so our clients understand where they have risks and opportunities.

FEATURED

Analyze sales performances across channels.

Consumer demographics and preferences.

See actual behaviors for actionable results.

Consumption — in and away from home.

We help our clients accelerate demand by focusing on the best opportunities for the greatest impact on their business.

FEATURED

Diagnostic, predictive, and prescriptive insights.

Reach the right audience at the right time.

Maximize every media dollar.

Improve retailer-supplier efficiency & effectiveness.

Resources

purple-gradient2.jpg
Spend-Tracker-Thumbnail.png

CPG Consumer Spend Tracker

Download our weekly U.S. consumer packaged goods sector monitoring report

New strategies and tactics.

Circana's official announcements.

Circana in the press.

Industry rankings vs. previous data period.

Deep expertise from global industry leaders.

Perspectives from our industry and thought leaders.

A curriculum to address your needs.

Solving challenges that matter to your business.

Growth-Insights-header1.jpg

Join Circana thought leaders, industry partners, and guests to learn how opportunities, trends, and market disruptions will impact your business.

U.S. Drug Channel Landscape Report

Posted in:

Category

Circana

Circana Media

SUMMARY Q1 2023 The U.S. Drug Channel Landscape Report for Q1 2023 follows up on trends identified in our 2022 drug channel analyses....

  • Writer: Circana
    Circana
  • Jun 4, 2023
  • 1 min read

SUMMARY


Q1 2023

The U.S. Drug Channel Landscape Report for Q1 2023 follows up on trends identified in our 2022 drug channel analyses. Find out how these trends compare to the broader multioutlet and convenience channel landscape. What are your most promising opportunities in the changing drug channel?

  1. In Q1 2023, drug channel sales continue to lag the multioutlet market as the channel laps last year’s significant growth during COVID-19 vaccination-led traffic.

  2. In U.S. inflation has softened, though consumers report financial anxiety — they’re consolidating trips to value channels and spending cautiously, which is negatively impacting traffic in the drug channel.

  3. Reduced need for home health care kits (COVID-19 test kits) led to the overall decline of the health department in Q1 2023, even though upper respiratory (e.g., cough/cold/flu-related items) grew 10.5%.


Report no longer available

About the author

View all solutions that

bottom of page